Cross-border transactions: A roadmap for commercial arrangements between North American and European companies
DOI:
https://doi.org/10.5912/jcb103Keywords:
cross-Atlantic transactions, strategic alliances, conflict of laws, intellectual property rightsAbstract
Major advances and breakthroughs in the biotechnology industry are increasingly reached through cross-Atlantic strategic alliances and collaborations. This paper explores some of the distinctions between biotech transactions that are between parties in different countries, particularly the US and EU members.
Downloads
Issue
Section
Article